Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

GlucoTrack Inc (GCTK)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow GlucoTrack's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.5980 +0.0580    +10.74%
03/05 - Closed. Currency in USD ( Disclaimer )
After Hours
0.5901
-0.0079
-1.3211%
21:50:11 - Real-time Data
  • Volume: 114,873
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 0.5300 - 0.6100
Type:  Equity
Market:  United States
GlucoTrack 0.5980 +0.0580 +10.74%

GlucoTrack Company Profile

 
Read the GlucoTrack Inc company profile to learn more about the business and the management team. View GlucoTrack Inc facts about employee data, company products and services, and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

6

Equity Type

ORD

GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

Contact Information

Address 301 Route 17 North Suite 800
Rutherford, 07070
United States
Phone 201 842 7715
Fax -

Top Executives

Name Age Since Title
Irl B. Hirsch - - Member of Scientific & Clinical Advisory Board
Michael Heise - - Member of Scientific & Clinical Advisory Board
Barry H. Ginsberg 79 - Member of Scientific & Clinical Advisory Board
Katharine Barnard - - Member of Scientific & Clinical Advisory Board
Jan Bolinder - - Member of Scientific & Clinical Advisory Board
Luis J. Malave 61 2021 Independent Chairman
Robert E. Fischell 95 2010 Independent Director
Shimon D. Rapps 44 2019 Independent Director
Avner Gal 70 2001 Co-Founder, Chairman Emeritus, Consultant and Member of Scientific & Clinical Advisory Board
Andrew Garrett Sycoff 57 2019 Director
Allen E. Danzig 67 2019 Independent Director
Erin Carter 54 2023 Independent Director
Lutz Walter Heinemann - 2015 Member of Scientific & Clinical Advisory Board
David C. Klonoff - 2021 Chair of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GCTK Price Commentary

Write your thoughts about GlucoTrack Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email